Press Release: Evolution of the Board of Directors
Retrieved on:
Monday, September 5, 2022
Exchequer and Audit Departments Act 1866, Corporation, CEO, Ministry, Annual general meeting, SAN, NASDAQ, Chief executive officer, Board, Science, Mass meeting, Board of directors, Social responsibility, CFO, Medicine, SNY, Group, Ministry of Finance (Azerbaijan), Rale, United Kingdom, Development, Patient, Management, Director, Sanofi
The Board of Directors of Sanofi met on September 2, 2022 and unanimously appointed Frdric Ouda as Censeur (non-voting member) of the Board with immediate effect.
Key Points:
- The Board of Directors of Sanofi met on September 2, 2022 and unanimously appointed Frdric Ouda as Censeur (non-voting member) of the Board with immediate effect.
- Following this Shareholders' Meeting, a proposal will be made to the Board of Directors of Sanofi to appoint Frdric Ouda as non-executive Chairman of the Board, replacing Serge Weinberg whose term of office will have expired.
- "I am delighted that Frdric Ouda has agreed to join the Board of Directors as Censeur and, if the General Meeting agrees, to become a director and succeed me as Chairman of the Board.
- "I am very pleased to join the Board of Directors of Sanofi as Censeur, with the prospect of becoming Chairman, if its shareholders approve, and I would like to thank the Board of Directors and its Chairman Serge Weinberg for their trust.